Acquirer | Target | Price |
---|---|---|
Allergan plc | Tobira Therapeutics Inc. | $533.6 million |
Inovalon Holdings, Inc. | Creehan & Company | $105 million |
Teva Pharmaceutical Industries | Collaboration on fasinumab | $250 million |
Allergan plc | Akarna Therapeutics Ltd. | $50 million |
Centric Health Corporation | CareRx Enterprises Ltd. | $14 million |